A multi-center, double-blind, randomized, parallel design study to compare the effectiveness of suvorexant versus placebo on sleep pressure and circadian rhythm in insomniacs with hypertension: The Super 1 study
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 04 Oct 2017
At a glance
- Drugs Suvorexant (Primary)
- Indications Insomnia
- Focus Therapeutic Use
- Acronyms Super 1
- 02 Oct 2017 Status changed from recruiting to active, no longer recruiting.
- 19 Jan 2017 Status changed from not yet recruiting to recruiting.
- 16 Aug 2016 New trial record